Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to ...
Tempus AI's diagnostics segment shows strong pricing power, with Oncology ASP rising from $1,630 to over $2,200. Read why TEM ...
While standard models suffer from context rot as data grows, MIT’s new Recursive Language Model (RLM) framework treats ...
Abstract: The minimum error entropy (MEE) criterion closely relies on the quadratic information potential (QIP) estimates of Renyi’s entropy. Nevertheless, the ...
Abstract: This article investigates a fixed-time adaptive fuzzy containment control problem for six-rotor multi-UAVs with flight route constraints and external disturbances. An effective adaptive ...
Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results